Table 1.
Mutation | Percentage of genomes in Oct 2021 | Frequency rank out of 7202 mutations | Selection Regime | Relative frequency changes in VOC lineages (alternative amino acid state) | Seen in other human beta CoV | |||
---|---|---|---|---|---|---|---|---|
α | β | γ | δ | |||||
S/67V | 0.435 | 85 | Positive* | ↑ | ↑ | |||
S/95I | 16.047 | 21 | Positive* | ↑ | ↑ | |||
S/142D | 0.002 | 5417 | Positive* | |||||
S/212I | 0.006 | 2814 | Negative | |||||
S/339D | 0.006 | 2883 | Negative | HKU1* | ||||
S/371L | <0.005 | >7202 | Negative | |||||
S/373P | 0.007 | 2719 | Negative* | |||||
S/375F | 0.003 | 4778 | Negative | |||||
S/417N | 0.529 | 73 | Positive* | (T) | OC43 | |||
S/440K | 0.156 | 216 | Positive* | ↑↑ (S) | ||||
S/446S | 0.007 | 2666 | Positive* | |||||
S/477N | 2.038 | 35 | Positive | ↑↑ (I) | ↑ (I) | HKU1* | ||
S/478K | 32.32 | 13 | Positive* | ↑ | SARS-1* | |||
S/484A | 0.004 | 3498 | Positive* | ↑ (K) | (K) | (K) | ||
S/493R | 0.007 | 2737 | Neutral | OC43 | ||||
S/496S | 0.013 | 1691 | Neutral | HKU1/OC43 | ||||
S/498R | <0.005 | >7202 | Negative | |||||
S/501Y | 37.036 | 2 | Positive* | |||||
S/505H | 0.003 | 4099 | Neutral | |||||
S/547K | 0.013 | 1740 | Positive | |||||
S/614G | 98.97 | 1 | Positive* | |||||
S/655Y | 2.513 | 30 | Positive | ↑ | ↑ | |||
S/679K | 0.041 | 534 | Positive | ↑ | OC43* | |||
S/681H | 35.613 | 3 | Positive* | (R) | ||||
S/764K | 0.005 | 3291 | Negative | |||||
S/796Y | 0.083 | 322 | Positive | SARS-1* | ||||
S/856K | <0.005 | >7202 | Negative* | OC43 | ||||
S/954H | <0.005 | >7202 | Negative | |||||
S/969K | <0.005 | >7202 | Negative* | HKU1* | ||||
S/981F | <0.005 | >7202 | Neutral |
Rows in bold indicate mutations at previously negatively selected or neutrally evolving sites. VOC columns track fold changes in mutation frequencies at corresponding sites in other VOCs (before and after boundaries are defined to create somewhat balanced sizes of sequence sets; the boundary is 2021/04/15 for α,β,γ and 2021/06/01 for δ). If another amino-acid residue is included in parentheses, then this residue has increased in frequency at the same site. ↑ - 2–10x fold increase ↑↑ - >10x fold increase. - lineage defining/majority mutation. (*) in other human beta-CoV - consensus residue in species matches the BA.1 residue; based on the sequence alignment from11